BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

870 related articles for article (PubMed ID: 18219308)

  • 1. Prodrugs: design and clinical applications.
    Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
    Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrug strategies to overcome poor water solubility.
    Stella VJ; Nti-Addae KW
    Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodrugs--from serendipity to rational design.
    Huttunen KM; Raunio H; Rautio J
    Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrugs: a challenge for the drug development.
    Zawilska JB; Wojcieszak J; Olejniczak AB
    Pharmacol Rep; 2013; 65(1):1-14. PubMed ID: 23563019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodrug approaches for CNS delivery.
    Rautio J; Laine K; Gynther M; Savolainen J
    AAPS J; 2008; 10(1):92-102. PubMed ID: 18446509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research of oral prodrugs: opportunities and challenges].
    Cao F; Ping QN; Chen J
    Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
    Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
    J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in prodrugs as drug delivery systems.
    Lin C; Sunkara G; Cannon JB; Ranade V
    Am J Ther; 2012 Jan; 19(1):33-43. PubMed ID: 21150770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development.
    Majumdar S; Duvvuri S; Mitra AK
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1437-52. PubMed ID: 15191791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codrug: an efficient approach for drug optimization.
    Das N; Dhanawat M; Dash B; Nagarwal RC; Shrivastava SK
    Eur J Pharm Sci; 2010 Dec; 41(5):571-88. PubMed ID: 20888411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is prodrug design an approach to increase water solubility?
    Sanches BMA; Ferreira EI
    Int J Pharm; 2019 Sep; 568():118498. PubMed ID: 31301465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodrug strategies in anticancer chemotherapy.
    Kratz F; Müller IA; Ryppa C; Warnecke A
    ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing for topical delivery: prodrugs can make the difference.
    Sloan KB; Wasdo S
    Med Res Rev; 2003 Nov; 23(6):763-93. PubMed ID: 12939791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
    Jana S; Mandlekar S; Marathe P
    Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric prodrugs.
    Azori M
    Crit Rev Ther Drug Carrier Syst; 1987; 4(1):39-65. PubMed ID: 3315236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What should be considered on design of a colon-specific prodrug?
    Jung Y; Kim YM
    Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acids as promoieties in prodrug design and development.
    Vig BS; Huttunen KM; Laine K; Rautio J
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1370-85. PubMed ID: 23099277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrug research: futile or fertile?
    Testa B
    Biochem Pharmacol; 2004 Dec; 68(11):2097-106. PubMed ID: 15498500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The delivery and antinociceptive effects of morphine and its ester prodrugs from lipid emulsions.
    Wang JJ; Sung KC; Yeh CH; Fang JY
    Int J Pharm; 2008 Apr; 353(1-2):95-104. PubMed ID: 18158222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to improve oral drug bioavailability.
    Gomez-Orellana I
    Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.